Side by side
| Manufacturer | Centres | Portfolio | Foreign GMP record | Supplied |
|---|---|---|---|---|
| China Resources Boya300294 · Fuzhou | 21 | 10 plasma · 31 presentations | Türkiye GMP cert · PH waiver | 7 |
| Beijing Bohui Innovation300318 · Beijing | 23 | 8 plasma · 27 presentations + 1 vaccine | None stated | 9 |
| Guangzhou BaiyunshanGPHL · Guangzhou | — | 1 vaccine | Registration not initiated | 1 |
Collection centres are the single best proxy for plasma capacity in China: manufacturers cannot buy plasma on the open market, so the number of licensed collection sites is the real ceiling on output. "Foreign GMP record" means an inspection or certificate from a regulator outside China — an NMPA approval number alone does not count.
Why only three
An export mandate is not a directory. Taking on a manufacturer means holding their dossier, releasing their documents, answering for their lead times and standing behind their batches in a market we can be sued in. Doing that for thirty companies would mean doing it badly for all of them.
Three manufacturers, seventeen products. Every product page names the manufacturer, the approval number and the document set. Nothing is listed that we cannot release paperwork for.
The three profiles
China Resources Boya Bio-pharmaceutical Group
The state-owned platform with the longest export record: Türkiye GMP certificate, Philippines GMP waiver, and IVIG already exported to Brazil. 21 collection centres, 10 plasma products.
Beijing Bohui Innovation Biotechnology Group
The largest collection footprint of the three, and the only one making a finished vaccine alongside its plasma range. 23 collection centres across four production sites.
Guangzhou Baiyunshan Biological Products
A single-product manufacturer inside the GPHL group: freeze-dried Vero-cell rabies vaccine, formulated without gelatin, antibiotics or preservatives. Overseas registration not yet initiated.
What a profile page is for
Each manufacturer page exists so that a buyer can answer three questions without an email: who the legal entity is, what they actually manufacture, and how to check the licences independently. The approval numbers, the batch-release rule and the public filings are all reachable — a supplier who would rather you did not look is telling you something.
Our compliance statement covers what we hold and what we do not, and Insights has the longer explanations of how Chinese drug approval and batch release work.